Literature DB >> 11696445

Thymic epithelial tumors can develop along two different pathogenetic pathways.

R Zhou1, A Zettl, P Ströbel, K Wagner, H K Müller-Hermelink, S Zhang, A Marx, P Starostik.   

Abstract

To investigate genetic abnormalities associated with the development of thymic epithelial tumors, we performed microsatellite analysis of 26 thymomas belonging to three different World Health Organization types (A, B3, and C) using 48 repeats. The most frequent aberration seen was loss of heterozygosity (LOH) in the region 6q23.3-25.3 detected in 11 tumors (45.8% of informative cases). Further consistent LOHs were detected in regions 3p22-24.2, 3p14.2 (FHIT gene locus), 5q21 (APC), 6p21, 6q21-22.1, 7p21-22, 8q11.21-23, 13q14 (RB), and 17p13.1 (p53). Microsatellite instability was extremely rare, occurring in one type B3 thymoma only, although, at 12.5% of the analyzed loci. Comparing the allelotypes of the analyzed thymomas, we were able to identify two pathogenetic pathways these tumors develop along, characterized by the 6q23.3-25.3 and 5q21 LOHs, respectively. The APC aberration on 5q21 showed significant associations with LOH in the 3p22-24.2, 13q14, and 17p13.1 regions. Interestingly, type A thymomas presented with consistent LOH in the region 6q23.3-25.5 only, they did not reveal any aberrations in the APC, RB, and p53 gene loci or regions 3p22-24.2 and 8q11.21-23. The absence of these aberrations might be the reason for the well-known benign behavior of type A thymomas as compared to types B3 and C tumors.

Entities:  

Mesh:

Year:  2001        PMID: 11696445      PMCID: PMC1867047          DOI: 10.1016/s0002-9440(10)63031-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Genetic aberrations common in gastric high-grade large B-cell lymphoma.

Authors:  P Starostik; A Greiner; A Schultz; A Zettl; K Peters; A Rosenwald; M Kolve; H K Müller-Hermelink
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

Review 2.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Thymic hyperplasia and neoplasia: a review of current concepts.

Authors:  G D Levine; J Rosai
Journal:  Hum Pathol       Date:  1978-09       Impact factor: 3.466

Review 4.  Pathological aspects of malignant and benign thymic disorders.

Authors:  H K Müller-Hermelink; A Marx
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

5.  Chromosome 6q involvement in human malignant melanoma.

Authors:  J M Trent; S B Rosenfeld; F L Meyskens
Journal:  Cancer Genet Cytogenet       Date:  1983-06

6.  Recurrent genetic aberrations in thymoma and thymic carcinoma.

Authors:  A Zettl; P Ströbel; K Wagner; T Katzenberger; G Ott; A Rosenwald; K Peters; A Krein; M Semik; H K Müller-Hermelink; A Marx
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours.

Authors:  F F Chen; J J Yan; K C Chang; W W Lai; R M Chen; Y T Jin
Journal:  Histopathology       Date:  1996-12       Impact factor: 5.087

8.  Partial 6q deletion in a human salivary gland adenocarcinoma.

Authors:  G Stenman; J Sandros; J Mark; S Edström
Journal:  Cancer Genet Cytogenet       Date:  1989-06

9.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

10.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more
  14 in total

1.  Chromosome 6 abnormalities correlated with thymoma progression.

Authors:  Hidefumi Sasaki; Yoshitaka Fujii; Nobuyuki Ide
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

3.  Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).

Authors:  Lothar Veits; Gunhild Mechtersheimer; Christina Steger; Jens Freitag; Gregor Mikuz; Kurt W Schmid; Walter Hofmann; Peter Schirmacher; Arndt Hartmann; Ralf J Rieker
Journal:  Virchows Arch       Date:  2011-07-07       Impact factor: 4.064

4.  Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas.

Authors:  Paolo A Zucali; Iacopo Petrini; Elena Lorenzi; Maria Merino; Liang Cao; Luca Di Tommaso; Hye Seung Lee; Matteo Incarbone; Beatriz A Walter; Matteo Simonelli; Massimo Roncalli; Armando Santoro; Giuseppe Giaccone
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

Review 5.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 6.  Thymic malignancies: from clinical management to targeted therapies.

Authors:  Ronan J Kelly; Iacopo Petrini; Arun Rajan; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2011-11-21       Impact factor: 44.544

7.  Chromosome 6 suffers frequent and multiple aberrations in thymoma.

Authors:  Masayoshi Inoue; Alexander Marx; Andreas Zettl; Philipp Ströbel; Hans-Konrad Müller-Hermelink; Petr Starostik
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

8.  Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.

Authors:  Yuqing Ma; Qiaoxin Li; Wenli Cui; Na Miao; Xia Liu; Wei Zhang; Chen Zhang; Jian Wang
Journal:  Diagn Pathol       Date:  2012-09-14       Impact factor: 2.644

9.  Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature.

Authors:  Maryam Maghbool; Mani Ramzi; Inga Nagel; Pablo Bejarano; Reiner Siebert; Abolfazl Saeedzadeh; Yahya Daneshbod
Journal:  BMC Clin Pathol       Date:  2013-05-31

10.  Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization.

Authors:  Gui Youn Lee; Woo Ick Yang; Hei Cheul Jeung; Sang Chul Kim; Min Young Seo; Chan Hee Park; Hyun Cheol Chung; Sun Young Rha
Journal:  BMC Genomics       Date:  2007-09-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.